is sitagliptin a glp 1 GLP-1-RA and DPP-4 inhibitors in the management of type 2 diabetes

Glucagon-like Peptide 1, Glucose-Dependent Insulinotropic Polypeptide, and Glucagon Receptor Agonists in Metabolic Dysfunction-Associated Steatotic Liver Disease: Novel Medication in New Liver Disease Nomenclature

25.64

★★★★☆4.8 (126)

First Time: Orally Available GLP-1 Agonist More Effective than DPP-IV Inhibitor | DZD

24.54

★★★★★4.9 (98)

Why is metformin plus sitagliptin not the preferred first‑line regimen compared with metformin plus a glucagon‑like peptide‑1 (GLP‑1) receptor agonist in an adult with type 2 diabetes, estimated glomerular filtration rate ≥45 mL/min/1.73 m²,

22.85

★★★★★5.0 (157)

Oral GLP-1-Based Therapeutics in the Obesity–Metabolic Syndrome–Diabetes Continuum: Translational Advances, Clinical Barriers, and Emerging Strategies

29.06

★★★★★4.7 (84)

GLP-1-RA and DPP-4 inhibitors in the management of type 2 diabetes

27.71

★★★★★4.9 (203)

These highlights do not include all the information needed to use SITAGLIPTIN TABLETS safely and effectively. See full prescribing information for SITAGLIPTIN TABLETS. SITAGLIPTIN tablets, for oral useInitial U.S. Approval: 2006

22.09

★★★★★5.0 (176)

GLP-1 and the kidney: from physiology to pharmacology and outcomes in diabetes

23.81

★★★★★4.8 (132)